Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2025-12-25 @ 5:35 PM
NCT ID:
NCT03099304
Pre Assignment Details:
157 participants were randomized to receive 1 of 4 dose strengths of ruxolitinib cream (0.15% once daily \[QD\], 0.5% QD, 1.5% QD, 1.5% twice daily \[BID\]) or vehicle during the 24-week, double-blind (DB), vehicle-controlled treatment period. After the DB period, 11 participants remained on 0.15% QD, and 42 participants who met criteria were re-randomized to 1 of the 3 higher active blinded treatment groups. All other participants remained on the same treatment regimen through Week 52.
Recruitment Details:
A total of 157 participants with vitiligo were treated at 26 study centers in the United States.
Study:
NCT03099304
Study Brief:
Results Section:
NCT03099304